OnQ Pain Pump Effectiveness in Post Operative Pain Control in Bariatric Patients

Morbid Obesity Clinical Trial

Official title:

OnQ Pain Pump Effectiveness in Post Operative Pain Control in Bariatric Patients

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT03159130
• Other study ID #: 371884-1
• Status: Withdrawn
• Phase: N/A
• First received: May 12, 2017
• Last updated: May 16, 2017
• Start date: June 2012
• Est. completion date: June 2014

Study information

• Verified date: May 2017
• Source: William Beaumont Army Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study will assess the efficacy of OnQ pain catheters in pain reduction in the bariatric surgical population and seeks to identify if a quantifiable improved post-operative course occurs in patients receiving a catheter filled with local anesthetic versus that achieved by patients who receive a catheter filled with injectable saline.

Description:

This study will assess the efficacy of OnQ pain catheters in pain reduction in the bariatric surgical population. Approximately 12 to 15 weight reduction surgeries are performed at William Beaumont Army Medical Center each month. It is the current practice that each patient receiving the laparoscopic gastric sleeve or laparoscopic Roux-en-Y gastric bypass receive an OnQ pain catheter during the surgery to reduce post-operative pain. There have been limited studies to quantify the efficacy of these devices. This study will seek to identify if a quantifiable improved post-operative course occurs in patients receiving a catheter filled with local anesthetic versus that achieved by patients who receive a catheter filled with injectable saline.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: June 2014
• Est. primary completion date: June 2014
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Meets criteria for Bariatric surgery

• Consents to be in protocol

• No local anesthetic allergy

• Will be having sleeve gastrectomy

• Doesn't have extensive scarring of abdominal wall that would prevent placement of OnQ catheter

Exclusion Criteria:

• declines to participate

Related Conditions & MeSH terms

• Morbid Obesity
• Obesity, Morbid
• Pain, Postoperative

Locations

Country	Name	City	State
United States	William Beaumont Army Medical Center	El Paso	Texas

Sponsors (1)

Lead Sponsor	Collaborator
William Beaumont Army Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Narcotic use	immediate post-operative narcotic use per patient	from admission to recovery room until discharge from the hospital (3-5 days)